Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
HCU gel oral powder 24g sachets
0913222B0BBABAB
|
HCU powder 10g protein equivalent | Powder 10g protein equivalent (0913222) | Nutrition and Blood | 9 |
|
Life On Haem-Life capsules
090607000BBMBBL
|
Proprietary compound preparation BNF 0906070 | Other multivitamin preparations | Nutrition and Blood | 9 |
|
Magn glycerophos (mag 97.2mg/5ml (4mmol/5ml)) susp
0905013G0AACZCZ
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 9 |
|
MagnaLac SR 84mg caplets
0905013P0BDAAAA
|
MagnaLac | Magnesium lactate | Nutrition and Blood | 9 |
|
Magnesium Diasporal 300 granules for oral solution sachets
0905013F0BCAAAE
|
Magnesium Diasporal 300 | Magnesium citrate | Nutrition and Blood | 9 |
|
Magnesium sulfate 50% (magnesium 2mmol/ml) inj 10ml ampoules
0905013N0AAAQAQ
|
Magnesium sulfate (Supplements) | Magnesium sulfate | Nutrition and Blood | 9 |
|
MagnEss Gly 97.2mg/5ml (4mmol/5ml) oral solution
0905013G0BHAEDJ
|
MagnEss Gly | Magnesium glycerophosphate | Nutrition and Blood | 9 |
|
Mevalia low protein pan rustico
0913261H0BBABAA
|
Mevalia specialist food replacer bread | Specialist food replacer bread (0913261) | Nutrition and Blood | 9 |
|
MMA / PA amino5 oral powder 6g sachets
0913203B0BBAAAA
|
MMA / PA amino5 powder 5g protein equivalent | Powder 5g protein equivalent (0913203) | Nutrition and Blood | 9 |
|
MSUD Lophlex powder 28g sachets
0913204C0BBABAB
|
MSUD powder 20g protein equivalent | Powder 20g protein equivalent (0913204) | Nutrition and Blood | 9 |
|
Multinutrient tablets
091200000AAFTFT
|
Generic compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | 9 |
|
Nutra-E 200unit capsules
0906050P0CZABAB
|
Nutra-E | Vitamin E | Nutrition and Blood | 9 |
|
PaediaSure Plus fibre Starter Pack liquid
0913021F0BDABAD
|
PaediaSure ready to serve 1.5 kcal/ml milkshake with fibre | Ready to serve 1.5 kcal/ml milkshake with fibre (0913021) | Nutrition and Blood | 9 |
|
Pharmaton Vitality capsules
090607000BBKFA0
|
Proprietary compound preparation BNF 0906070 | Other multivitamin preparations | Nutrition and Blood | 9 |
|
Phytomenadione 10mg capsules
0906060Q0AABCBC
|
Phytomenadione | Phytomenadione | Nutrition and Blood | 9 |
|
PK Foods Aminex low protein rusks
0913261R0BDABAD
|
PK Foods specialist food replacer savoury biscuits | Specialist food replacer savoury biscuits (0913261) | Nutrition and Blood | 9 |
|
PK Foods low protein flour mix
0913261G0BFAAAF
|
PK Foods specialist food replacer flour type mix | Specialist food replacer flour type mixes (0913261) | Nutrition and Blood | 9 |
|
PKU Air15 red liquid
0913205M0BBADAB
|
PKU ready to serve 15g protein equivalent (0913205) | Ready to serve 15g protein equivalent (0913205) | Nutrition and Blood | 9 |
|
Pro D3 4,000unit tablets
0906040G0BIATEE
|
Pro D3 | Colecalciferol | Nutrition and Blood | 9 |
|
Pyridoxine 300mg/5ml oral solution
0906024N0AACJCJ
|
Pyridoxine hydrochloride | Pyridoxine hydrochloride | Nutrition and Blood | 9 |
|
Slow-K 600mg tablets
0902011U0BGAAAH
|
Slow-K | Potassium chloride | Nutrition and Blood | 9 |
|
SunVit-Pro Calcium carbonate 1.5g chewable tablets
0905011D0BKABAK
|
SunVit-Pro Calcium carbonate | Calcium carbonate | Nutrition and Blood | 9 |
|
ThiaDose 50mg tablets
0906026M0BKABAF
|
ThiaDose | Thiamine hydrochloride | Nutrition and Blood | 9 |
|
TYR express15 oral powder 25g sachets
0913206A0BBAAAA
|
TYR powder 15g protein equivalent | Powder 15g protein equivalent (0913206) | Nutrition and Blood | 9 |
|
Valupak Calcium & Vitamin D tablets
0906040N0BJABEE
|
Valupak Calcium with Vitamin D | Ergocalciferol | Nutrition and Blood | 9 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.